AIM ImmunoTech AIM
NYSE AIM
$0.19 +0.01 (+7.31%)
As of: Oct 1, 2026 · 3:59 PM EDT

AIM ImmunoTech (AIM) Net Equity Issued and Repurchased (2010 - 2026)

Updated

AIM ImmunoTech's Net Equity Issued and Repurchased came in at $3.58 million for Q2 2026, compared with $105,000 a year earlier and up 65.9% from the prior quarter.

Analysis

AIM ImmunoTech (AIM) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, AIM ImmunoTech reported Net Equity Issued and Repurchased of $12.28 million, up 497.1% year-over-year; for FY2025, it was $7.31 million, up 720.0% from FY2024.

  • Net Equity Issued and Repurchased has increased in each of the last three years, though with a five-year compound annual growth rate of -34.6% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $892,000 in FY2024 (+83.9%), $485,000 in FY2023 (+506.3%), $80,000 in FY2022 (-99.4%) and $13.04 million in FY2021 (-78.7%).
  • The five-year range for quarterly Net Equity Issued and Repurchased is -$398,000 (Q3 2025) to $6.95 million (Q4 2025).
  • Year-over-year, Net Equity Issued and Repurchased increased in three of the last five quarters, with growth averaging 121.9%.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q3 2023 (growth of 832.0%), and the weakest in Q3 2021 (a decline of 99.8%).
  • Business Quant data shows AIM's Net Equity Issued and Repurchased at $2.16 million (Q1 2026), $6.95 million (Q4 2025) and -$398,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 AIM ImmunoTech 3.08 Mn -18.22 Mn 21,000.00 3.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.58 Mn
Mar 31, 2026 2.16 Mn
Dec 31, 2025 6.95 Mn
Sep 30, 2025 -398,000.00
Jun 30, 2025 105,000.00
Mar 31, 2025 660,000.00
Dec 31, 2024 32,000.00
Sep 30, 2024 4,000.00
Jun 30, 2024 527,000.00
Mar 31, 2024 329,000.00
Dec 31, 2023 147,000.00
Sep 30, 2023 233,000.00
Jun 30, 2023 5,000.00
Mar 31, 2023 100,000.00
Sep 30, 2022 25,000.00
Dec 31, 2021 125,000.00
Sep 30, 2021 30,000.00
Mar 31, 2021 12.89 Mn
Dec 31, 2020 3.18 Mn
Sep 30, 2020 17.25 Mn
API Access

AIM ImmunoTech Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AIM&period=max&api_key=YOUR_API_KEY